Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Tarun Tejpal conviction: 10 key observations that shaped Bombay HC verdict

The Bombay high court overturned Tarun Tejpal's acquittal in a sexual assault case. He received a ten-year rigorous imprisonment sentence and a substantial fine. The court found his apology emails to be key evidence of guilt. Victim's testimony was deemed credible and consistent despite extensive questioning. The court criticized the trial court's treatment of the victim during proceedings.

Tarun Tejpal conviction: 10 key observations that shaped Bombay HC verdict

The Bombay High Court has overturned former Tehelka editor-in-chief Tarun Tejpal's 2021 acquittal in the 2013 sexual assault case, convicting him under multiple provisions of the Indian Penal Code and sentencing him to 10 years' rigorous imprisonment with concurrent sentences. The court also ordered him to pay a total of Rs 10.1 lakh in fines to the victim.

The judgment considered the evidence, victim's testimony, and the conduct of the original trial, rejecting claims of extortion and character assassination. The position of power that Tejpal held over the victim, as her mentor, friend of her father, and influential figure in the journalism world, was a significant factor in the court's decision to convict him under aggravated rape provisions.

Written by urgent.news from Times of India's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at timesofindia.indiatimes.com →

More in Health & Medicine

Iran war renews concerns about the lasting toll of traumatic brain injuries to US troops

WASHINGTON (AP) — When Joe Shearer was a Marine fighting in Iraq, a blast from an enemy mortar round knocked him down and made him vomit. He got up and kept going despite a searing…

  • Ongoing Iran war raises concerns over long-term TBI impact on troops.
  • Nearly 700 U.S. service members wounded by drone and missile attacks.
  • Doctors uncertain about lasting effects of TBIs, some experience lasting symptoms.

FDA Approves First mRNA Flu Shot

The FDA has approved the first mRNA flu vaccine in the United States after a clinical trial found it was about 27% more effective than a standard flu shot.

  • FDA approves first mRNA flu vaccine, mFlusiva
  • 27% higher efficacy than conventional flu shot
  • Marketed for adults 50+, older adults pending trials

More from Thursday 6 August →